DocMorris AG (SWX: DOCM)
37.04
-1.18 (-3.09%)
Sep 4, 2024, 1:54 PM CET
DocMorris AG Company Description
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally.
The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products.
It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands.
The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023.
DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
DocMorris AG
![DocMorris AG logo](https://img.stockanalysis.com/logos1/SW/ROSE.png)
Country | Switzerland |
Founded | 1993 |
Industry | Pharmaceutical Retailers |
Sector | Healthcare |
Employees | 1,453 |
CEO | Walter Hess |
Contact Details
Address: WalzmUehlestrasse 49 Frauenfeld, 8500 Switzerland | |
Website | corporate.docmorris.com |
Stock Details
Ticker Symbol | DOCM |
Exchange | SIX Swiss Exchange |
Fiscal Year | January - December |
Reporting Currency | CHF |
ISIN Number | CH0042615283 |
SIC Code | 5961 |
Key Executives
Name | Position |
---|---|
Walter Hess | Chief Executive Officer and Member of Executive Board |
Walter Oberhansli | Founder and Chairman |
Marcel Ziwica | Chief Financial Officer and Member of Executive Board |
David Maso | Head of Europe and Member of Executive Board |
Madhu Nutakki | Chief Technology Officer and Member of Executive Board |
Kaspar Niklaus | Chief Operating Officer and Member of Executive Board |
Dr. Daniel Grigat | Group Head of Investor Relations and Sustainability |
Torben Bonnke | Director of Communications |